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Although prospective studies of defibrillator shock overdose cannot be performed in man, the 
therapeutic indices of various defibrillating current waveforms can be measured in animals. We 
determined the ratios TD50/ED50 and LD50/ ED50 (where TD50 = median "toxic" or damage- 
inducing dose, ED50 = median effective or defibrillating dose, and LD50 = median lethal dose) as 
measures of the therapeutic index for damped sine wave defibrillator shocks in dogs. Death of an 
animal and/or any degree of cardiac damage found by gross or microscopic examination were 
defined as harmful effects of shock, analogous to drug toxicity. In terms of peak current, the 
ED50, TD50, and LD50 were 1.1, 5.8, and 24 amperes/ kg; the therapeutic indices were TD50/ED50 
= 5 for morphologic damage and LD50/ED50 = 22 for death. In terms of delivered energy the 
ED50, TD50, and LD50 were 1.5, 30, and 470 joules/kg; the therapeutic indices were TD50/ED50 
= 20 for damage and LD50/ED50 = 320 for death. These data indicate a reasonable margin of 
safety for damped sine wave defibrillator shocks in dogs, and are consistent with reported 
incidences of suspected shock-induced damage in humans. 
 
 













Ventricular defibrillation by an electric shock applied across the chest is a lifesaving, but not 
necessarily innocuous, clinical procedure. Animal studies have demonstrated both morphologic 
damage and functional impairment of the heart following defibrillator shocks.  Indirect evidence 
for shock-induced myocardial damage in man includes ECG changes, elevated cardiac 
isoenzyme levels in plasma, and positive scintigrams. In order to prescribe the safest and most 
effective electrical dose for defibrillation, knowledge of the margin of safety for defibrillator 
shocks is required. The classical pharmacologic measure of the margin of safety of a drug is the 
therapeutic index, which may be defined as the ratio of either the median toxic or the median 
lethal dose to the median effective dose. Because harmful effects cannot be intentionally induced 
in human subjects, it is necessary to consider this relationship between effective and damaging 
electrical doses in experimental animals. The present study establishes therapeutic indices for 





The experimental defibrillator 
 
Investigations of the therapeutic and damaging effects of single, damped sine wave shocks were 
conducted with our experimental, high energy defibrillator [1]. The energy storage capacitor of 
this device could be varied from 0 to 100 microfarads; the series inductance could be varied from 
0 to 100 millihenries; and the initial voltage of the capacitors could be varied continuously from 
0 to 10,000 volts. For the study of effective shock strengths the operating mode of the 
experimental defibrillator was selected to simulate a typical clinical unit (16 or 32 microfarads, 
50 or 100 millihenries, 0 to 400 joules stored energy). In this mode of operation the output pulse 
duration (time between pulse onset and first zero crossing of the underdamped sine wave), which 
is somewhat dependent upon subject resistance, averaged 5.1 msec For the study of "toxic" 
shock strengths greater defibrillator capacitance (50 microfarads) charged to higher initial 
voltages (5,000 to 10,000 volts) was required in order to deliver sufficient energy to produce 
myocardial damage. In this mode of operation shock durations averaged 7.4 msec To achieve the 
highest electrical dose tested, corresponding roughly to the LD50, a capacitance of 100 
microfarads charged to 10,000 volts was necessary in 6 of 11 animals in one group. With 100 
microfarad capacitance the output waveform was an overdamped sine wave, as described in 
reference [10], and in this case the pulse duration was taken as the time required for the pulse to 
decay to 10 percent of its peak value. 
 
In both studies the current waveforms were similar to those delivered by conventional damped 
sine wave defibrillators. The delivered pulse durations were within the 2 to 10 msec range 
described for clinical defibrillators by Finlay [11] and within the 4 to 8 msec range we calculated 
for typical commercially available, damped sine wave defibrillators using published values for 
output circuit components [12] and for the range of human thoracic resistances (25 to 105 ohms) 






In the first study, reported in detail elsewhere [14], shocks of a strength near the defibrillation 
threshold were tested for their efficacy in defibrillating the ventricles of 36 dogs, average weight 
14 ± 7* kg, in which fibrillation was produced by electrical stimulation of the right ventricular 
endocardium. Transchest ventricular defibrillation threshold was determined in each animal by 
repeated trials with successive shocks of diminishing peak current amplitude, each shock being 
10% less than that of the preceding shock. The shocks were administered via 8 cm. electrodes in 
12 dogs weighing less than 10 kg and via 10 cm electrodes in the larger dogs. The ventricles 
were never permitted to fibrillate for longer than 30 seconds, and another fibrillation-
defibrillation episode was never conducted until systemic blood pressure had returned to a stable 
level. 
 
In the second study of damaging and lethal effects, a single high intensity damped sine wave 
shock was given to each of 65 dogs, average weight 8 ± 2 (SD) kg, via 10 cm. diameter 
transchest electrodes. Details of this protocol have been reported previously [15]. In brief, each 
dog was assigned either to a control group which received no shock or to one of six experimental 
groups which received an unsynchronized shock of approximately 1, 3, 6, 9, 12, 15, or 20 
amperes peak current per kilogram body weight (90 to 4,700 joules total delivered energy). To 
calculate the voltage setting required to deliver the desired current, the apparent chest impedance 
to 50 KHz, non-stimulating, sinusoidal current was measured as described by Geddes and 
associates [16]. Delivered energy was calculated as previously described [12] form current and 
voltage waveforms registered on a storage oscilloscope. Mean delivered energy doses for the 
groups of animals ranged from 1 to 512 joules per kilogram body weight. The hearts were in 
normal sinus rhythm, rather than fibrillation, when the unsynchronized shocks were applied to 
ensure that any observed damage was due to the shock and not to pre-existing circulatory arrest. 
 
Hearts of animals that died immediately after shock, as well as hearts of animals that survived 
and were later killed, were removed from the thorax promptly after death. Gross cardiac lesions 
were observed carefully and were graded according to predetermined criteria [15]. Entire hearts 
were then fixed in 10% neutral buffered formalin. Blocks of myocardial tissue from 22 
standardized sites were collected, embedded in paraffin, sectioned, and stained with hematoxylin 




Determination of efficacy, damage, and lethality curves 
 
The criterion for efficacy of transchest shocks was ventricular defibrillation. For each of 36 dogs 
in the efficacy study, five to 20 threshold energy values were obtained and averaged. Histograms 
were constructed using these mean values to illustrate animal-to-animal variations in threshold 
within this population. Percent successful defibrillation vs. electrical dose curves were 
constructed for the 36 dogs according to the method of Goldstein and colleagues [17] by 
integrating the threshold energy histograms. Using this technique, it was possible in particular to 
establish the 50% effective dose or ED50 for the population, since one half of the dogs had 
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defibrillation thresholds below this value and the other half of the dogs had defibrillation 
thresholds above this value. 
 
The criterion for "toxicity" of transchest shocks was any degree of morphologically detectable 
myocardial damage. According to this criterion, a heart was scored as damaged if there were any 
gross lesions present or if any of the 22 blocks taken for histologic study showed defibrillator- 
induced necrosis of muscle fibers, epicardial reaction, or both. In addition, the hearts of dogs that 
died within 15 minutes after shock were scored as damaged, although gross and microscopic 
lesions were often subtle at this early time after injury. The percentage of animals defibrillated, 
damaged, or killed by shock in each dose group were plotted as functions of the current or 
energy dose per kilogram body weight. Normalization of dose by body weight is classically 
employed in experimental pharmacology and has proved of value in earlier defibrillation studies 
[18]. For such plots, smooth curves were fitted to experimental data by probit transformation and 
linear regression, using the method of Litchfield and Wilcoxon [19] and interpolated values were 





Figure 1 shows the incidence of defibrillation, morphologic damage, and death as functions of 
delivered peak current in amperes/kg In terms of peak current the ED50, TD50, and LD50 were 
1.1, 5.8, and 24 amperes/kg, respectively. These values represent the median current doses which 
were capable of defibrillating, damaging, and killing 50% of the animals studied. The 
corresponding therapeutic indices are TD50/ED50 = 5 for morphologically detectable damage and 
LD50/ED50 = 22 for death. Thus, it took five times as much peak current to produce detectable 





Figure 1.  Current dose-response curves for defibrillation morphologic damage, and 




Figure 2 shows the incidences of defibrillation, morphologic damage, and death as functions of 
delivered energy in joules/kg The ED50, TD50, and LD50 were 1.5, 30, and 470 joules/kg. The 
corresponding therapeutic indices were TD50/ ED50 = 20 for damage and LD50/ED50 = 320 for 
death. Hence, it took 20 times as much energy to produce detectable damage in a typical dog and 
320 times as much energy to kill a typical dog than it did to defibrillate. The larger numerical 
dose range and the larger therapeutic indices may be expected when energy is used to describe 





Figure 2.  Energy dose-response curves for defibrillation, morphologic damage, and 
death. The delivered energy has been normalized to body weight. 
 
 
The slopes of the curves of Figures 1 and 2 indicate considerable biologic variability among dogs 
in their susceptibility to defibrillation, damage, or death. Variability in susceptibility to the 
harmful effects of shock was remarkable. For example, an electrical dose of 120 joules/kg was 
sufficient to kill 10% of the animals; however, this same dose produced no detectable damage in 
12% of the animals, while the remaining 78% showed varying degrees of damage. Despite this 
biologic variability, the therapeutic indices were sufficiently large so that there was no overlap 
between the death and the defibrillation curves and only slight overlap between the morphologic 
damage and the defibrillation curves. The calculated curves indicate that the risk of detectable 
damage was 2 to 4% for 90% successful shocks and 5 to 10% for 99% successful shocks. This 
degree of overlap between the efficacy and toxicity curves is similar regardless of whether 







The studies described in the present paper indicate that therapeutic indices may be calculated for 
defibrillator shocks on the basis of reasonable criteria for effectiveness and "toxicity." The 
resultant values may be interpreted in a manner analogous to therapeutic indices of drugs. 
Although similar, studies of intentional shock overdose cannot be performed in man; the 
therapeutic indices of various defibrillating current waveforms can be measured in animals in 
order to design defibrillators with the greatest margin of safety. 
 
The relatively large therapeutic indices reported here for animals indicate a reasonable safety 
margin for damped sine wave defibrillator shocks. Extrapolation of this conclusion to the clinical 
arena, however, must be done with caution. The present studies were conducted in healthy 
animals with normal rather than diseased hearts. Moreover, in the efficacy study the time of 
circulatory arrest due to fibrillation was less than 30 seconds, and in the damage study shocks 
were administered to beating hearts. In general the hearts of animals in both studies were 
relatively well oxygenated. Human hearts in clinical situations are typically diseased and may be 
poorly oxygenated at the time of defibrillation. Under these less favorable conditions the 
therapeutic indices for defibrillation may be significantly different from those reported here. 
 
Nonetheless, the available clinical data seem to confirm the relatively low incidence and extent 
of shock-induced damage we have observed at therapeutic shock strengths in dogs. Ehsani and 
colleagues [8] and Werner and associates [20] have shown 7 and 8% incidence, respectively, of 
indirect evidence for damage in humans after high cumulative energy doses from defibrillators. 
Accordingly, in view of both the animal and the human data available at this writing, we believe 
that fear of inducing damage should not be a dominant factor in determining defibrillation dose. 
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